ABSTRACT A major medical challenge in the elderly is osteoporosis and the high risk of fracture. Telomere dysfunction is a cause of cellular senescence and telomere shortening, which occurs with age in cells from most human tissues, including bone. Telomere defects contribute to the pathogenesis of two progeroid disorders characterized by premature osteoporosis, Werner syndrome and dyskeratosis congenital. It is hypothesized that telomere shortening contributes to bone aging. We evaluated the skeletal phenotypes of mice with disrupted telomere maintenance mechanisms as models for human bone aging, including mutants in Werner helicase (Wrn *Author for correspondence (pignolo@mail.med.upenn.edu) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
INTRODUCTION
Human senile osteoporosis is generally characterized by low bone mass and altered microarchitectural features, primarily attributed to osteoblast dysfunction, which results in a substantially increased risk of fracture and subsequent disability (Kassem and Marie, 2011; Marie and Kassem, 2011a; Marie and Kassem, 2011b) . This differs from well-studied postmenopausal osteoporosis, in which significant bone loss is attributed to increased osteoclast resorption concomitant with the loss of estrogen in women (Aaron et al., 1987; Rehman et al., 1994; Russo et al., 2003; Mullender et al., 2005; Pernow et al., 2009) . One of the limitations to more intensive investigations of senile osteoporosis is the lack of physiologically relevant models of aging bone. Although the mechanisms of senile osteoporosis remain to be elucidated, some mechanistic clues have come from genetic conditions that potentiate telomere dysfunction. Two conditions of particular interest include dyskeratosis congenita (DC; incidence ~1 in 1 million) and Werner syndrome (WS; incidence 1 in 20,000-200,000), both of which are characterized by a complex phenotype including premature osteoporosis. In DC, osteoporosis is an accelerated form of that seen with physiological aging, whereas the osteoporosis of WS affects the limbs as well as the axial skeleton (Hofer et al., 2005; Mason et al., 2005) . One of the most common forms of DC is caused by a mutation in TERC (the RNA template component of telomerase), which results in reduced telomerase activity. The lack of telomerase activity leads to prematurely shortened telomeres, telomere uncapping and the association of telomeric ends with DNA-damage proteins. Taken together, these findings suggest that dysfunctional telomeres likely are a major contributing factor to the pathology of DC, including osteoporosis (Mason et al., 2005) .
WS is most commonly due to a loss-of-function mutation in WRN, which encodes a DNA helicase of the RecQ family and functions in the recombinational repair of stalled replication forks or double-strand breaks (Ozgenc and Loeb, 2005) . Additionally, WRN is thought to play a role in telomere maintenance (Wyllie et al., 2000; Johnson et al., 2001; Opresko et al., 2002; Crabbe et al., 2004) , which might be particularly important in situations when telomeres become dysfunctional, such as cellular aging.
In mice lacking telomerase and with shortened telomeres, Wrn −/− mutation results in an acceleration of defects seen in Terc −/− mutants and also the appearance of some pathologies typical of WS (e.g. osteoporosis) (Chang et al., 2004; Du et al., 2004) . Previously, we and others found that deficiency in telomerase, alone or in combination with deficiency in the Werner helicase, leads to an accelerated low-bone-mass phenotype (Chang et al., 2004; Du et al., 2004; Pignolo et al., 2008; Saeed et al., 2011) . Declines in mesenchymal progenitor cell number and in osteoblast differentiation are the major cellular mechanisms associated with premature bone loss (Pignolo et al., 2008; Wang et al., 2012 (Pignolo et al., 2008; Wang et al., 2012) .
Here, we test the hypothesis that deficiencies in Terc −/− and/or Wrn −/− Terc −/− mutant mice reflect many of the physiological features of human age-related osteoporosis, including decreased bone volume, osteoblast number and osteoblast function, as well as increased porosity and marrow adiposity. We present evidence that supports the use of Terc −/− and Wrn −/− Terc −/− mice as relevant models for studying human age-related osteoporosis and suggests that telomere-based mechanisms are important in the aging of bone tissue.
RESULTS
Telomere-based aging models show accelerated trabecular and cortical bone loss A hallmark of human senile osteoporosis is decreased bone volume, primarily attributed to decreased trabecular bone, which can also be accompanied by decreased cortical bone volume (Parfitt, 1984; Kleerekoper et al., 1985; Rehman et al., 1994; Mullender et al., 2005; Pernow et al., 2009 Human senile osteoporosis can be accompanied by thinning of the cortical shell and increased cortical porosity causing an increased risk of fracture (Feik et al., 1997; Bousson et al., 2001; Ostertag et al., 2009; Nishiyama et al., 2010; Zebaze et al., 2010) . Cortical bone was analyzed for both young and aged mice at the femoral midshaft using μCT. Fig. 2A showed a decrease (4.0%) in cortical area compared with agematched WT ( Fig. 2A,B 
TRANSLATIONAL IMPACT

Clinical issue
Human age-related osteoporosis poses a major problem to both elderly men and women. The low bone mass and altered microarchitectural features of the condition, which are mainly attributed to osteoblast dysfunction, increase the risk of bone fracture. It is predicted that the annual number of hip fractures worldwide due to osteoporosis will rise threefold from the 1990 figure of 1.7 million to 6.3 million by 2050. Therefore, it is crucial to develop novel therapies to help treat this condition. Although postmenopausal osteoporosis, which is attributed to increased osteoclast activity (osteoclasts destroy bone whereas osteoblasts build bone; normal bone is constantly remodeled by these two cell types), has been well studied, far less is known about the mechanisms of age-related osteoporosis. This is in part due to a lack of physiologically relevant models of this type of osteoporosis.
Results
Here, the authors investigate the premature osteoporosis that occurs in mouse models based on two human genetic progeroid (premature aging) conditions, Werner syndrome and dyskeratosis congenita. Telomere defects contribute to both of these disorders, and telomere shortening occurs with age in cells from most human tissues, including bone. 
Wrn
-/-double-mutant mice and the human condition, the authors evaluate the skeletal phenotypes of the mutant mice. They show that these models reflect the major features of senile bone loss, including decreased trabecular and cortical bone volume, increased cortical porosity, and impairment of osteoblast function as a prominent cause of accelerated bone aging.
Implications and future directions These findings suggest that Terc -/-and Wrn -/-
Terc -/-mice recapitulate the bone changes that occur in aging human bones and establish these mice as appropriate models for studying senile osteoporosis. Moreover, they support the hypothesis that telomere-based mechanisms are important in bone aging. The models described will be useful for the identification and dissection of signaling pathways that are altered in response to telomere-based bone aging. Moreover, further studies incorporating these models should aid in the design and preclinical evaluation of potential therapeutic treatments for age-related bone loss.
Terc −/− mice was significantly increased (P=0.0008 and P=0.0024, respectively).
Taken together, our data show that the accelerated bone aging in Terc −/− and Wrn −/− Terc −/− mouse models not only displays characteristic features of human senile osteoporosis, as examined at the structural level by μCT, but that these characteristics present earlier and in general are more pronounced than in older WT mice.
Osteoblast dysfunction is the primary cellular mechanism for osteoporosis in telomere-based bone aging
The decrease in bone volume seen in human senile osteoporosis is generally attributed to decreased bone formation due to osteoblast dysfunction, in contrast to menopausal osteoporosis in which increased osteoclast resorption seems to be the predominant mechanism (Rehman et al., 1994; Clarke et al., 1996; Pernow et al., 2009) . Therefore, to assess osteoblast function, calcein double labeling was used to quantify dynamic parameters of bone formation in young and aged mice (Fig. 3A) 
DISCUSSION
Senile osteoporosis results in a substantially increased risk of fracture and subsequent disability (Raisz and Rodan, 2003) . Although postmenopausal osteoporosis has been well studied, far less is known about the mechanisms of age-related osteoporosis affecting both men and women. In this study, we assessed telomerebased aging mouse models according to key characteristics of human senile bone loss, both to evaluate their physiological similarities to the human condition as well as to substantiate the importance of telomere dysfunction as a mechanism for skeletal aging. Although previous data suggest that telomerase-based models of accelerated aging have osteoporosis, our current study shows that these models reflect the major features of senile bone loss, and that impairment of osteoblast function is a prominent aspect of accelerated bone aging. Inadequate osteoblast-mediated mineralization during bone remodeling is likely to be responsible for osteopenia in mouse models of physiologic as well as premature aging (Jilka, 2013) . Bone loss in both trabecular and cortical locations is a hallmark of age-related osteoporosis. Similar to human senile osteoporosis, Terc −/− and Wrn −/− Terc −/− mice had decreased trabecular bone volume and trabecular number (Table 1) . A significant decrease in Terc −/− trabecular bone has also been reported (Saeed et al., 2011 ) from histological analysis in the spinal region (L5 vertebra). Although trabecular thickness also decreased with age in our models, no consensus has been reached for humans, where reports have shown a decline in trabecular thickness (Parfitt et al., 1983; Birkenhäger-Frenkel et al., 1988) , a decline in men only (Wakamatsu and Sissons, 1969; Aaron et al., 1987; Mellish et al., 1989) , and a decline in both men and women (Rehman et al., 1994) . These discrepancies could be attributed to human variation; however, when looking at severely osteoporotic male bone samples, Pernow et al. showed that trabecular thickness was significantly decreased (Pernow et al., 2009 ).
Cortical bone loss in human senile osteoporosis is structurally identified by cortical thinning and increased porosity (Feik et al., 1997; Ostertag et al., 2009; Nishiyama et al., 2010; Zebaze et al., 2010; Macdonald et al., 2011) . μCT analysis of Terc −/− and Wrn
−/−
Terc
−/− mice showed that they recapitulate this phenotype by having both a significant decrease in cortical thickness and a significant increase in porosity, which together contributed to the significant loss of cortical bone volume compared with WT mice (Table 1) .
Age-related bone loss in humans is attributed to osteoblast dysfunction in the presence of normal osteoclast activity (Marie and Kassem, 2011b trabecular bone had statistically increased SMIs in both young and aged groups, consistent with changes seen in aging bone that demonstrate a transition from a more plate-like trabecular structure to a more rod-like structure typical of osteoporotic bone (Ding and Hvid, 2000; Chen et al., 2013) . Although the DA varies with skeletal site, with human bone aging there is initially an increase in anisotropy followed by a period of trabecular perforation and an eventual decrease in anisotropy (Jiang et al., 2005 (Bono and Einhorn, 2003; Russo et al., 2003) .
In bone, there seems to be a reciprocal relationship between the number of osteoblasts and adipocytes, with increased bone-marrow adiposity manifesting as another prominent feature of human senile osteoporosis (Justesen et al., 2001; Rosen and Bouxsein, 2006 involved using mouse strains that had a low peak bone mass, including C57BL/6J, that would develop osteoporosis naturally with age (Matsushita et al., 1986; Perkins et al., 1994; Bergman et al., 1996; Takeda et al., 1997b; Takeda et al., 1997a; Takeda et al., 1997c; Cao et al., 2003; Ferguson et al., 2003) . However, the long time over which these strains develop characteristic features of bone aging make these models less appealing. To obviate this problem, strategies were implemented to mimic bone aging through ovariectomy, orchiectomy or bone-marrow ablation (Wink and Felts, 1980; Kalu, 1984; Liang et al., 1992; Mosekilde et al., 1994; Zhang et al., 1998) . Although these approaches will cause an osteoporotic phenotype, they are better models for secondary causes of bone loss (e.g. sex-hormone deficiency) rather than primary age-related osteoporosis. Advantages and limitations of mouse models for the study of bone aging, and their applicability to the human condition, have been comprehensively reviewed (Jilka, 2013) .
The use of genetically modified animals has enabled the development of osteoporotic mouse models (Kawaguchi et al., 1999; Vogel et al., 1999; Li et al., 2000; Bonyadi et al., 2003; Ito et al., 2003; Sun et al., 2004; Rasheed et al., 2006) , but raises the question of how to qualify genetic changes as relevant to age-related bone loss specifically. The gene(s) modified in a proposed model of senile osteoporosis should (a) effect osteoblast differentiation and/or function; (b) accelerate the processes naturally impacted by aging, preferably on both the cellular and organismal level; and (c) result in a bone phenotype that recapitulates aspects of age-related bone loss in humans. Previous research has validated the influence of the Wrn and Terc genes on aging (Epstein et al., 1966; Chang et al., 2004; Mason et al., 2005; Ozgenc and Loeb, 2005 mutations in mice cause a bone phenotype very similar to that seen in age-related bone loss in humans (Table 1) , including osteoblast dysfunction, and thus are appropriate models for studying senile osteoporosis.
MATERIALS AND METHODS
Animals
The University of Pennsylvania Institutional Animal Care and Use Committee approved the use of mice described in this study. Mutant mice had the Wrn −/− and Terc −/− alleles backcrossed on the C57BL/6J background (for >11 generations). Fourth-generation (G4) Wrn −/− Terc −/− mice were produced as previously described (Pignolo et al., 2008; Wang et al., 2012 
Terc
−/− mutants were sacrificed by 15 months or earlier, when they exhibited signs of significant suffering and impending demise including severe lethargy and/or major (>15%) weight loss. Based on our previous experience, animals exhibiting these moribund features died within 1 week. The average age of the older Terc −/− group was 11 months of age and that of the older Wrn
−/−
Terc
−/− group 10 months of age.
μCT analysis Trabecular and cortical bone
High-resolution images of femurs were acquired by using a Scanco VivaCT 40 device (Bruettisellen, Switzerland). The femurs were scanned with a source voltage of 55 kV, a source current of 142 μA and an isotropic voxel size of 10.5 μm. After scanning, three-dimensional image data was reconstructed and structural indices were calculated using Scanco μCT V6.1 software.
The area for trabecular analysis started 57.5 μm proximal from the growth plate at the distal end of the femur and extended proximally 1050 μm toward the femoral head. The ROI for measurement of trabecular microarchitectural variables was defined manually by outlining the bone within the endocortical margins and allowing a few voxels between the ROI and the endocortical margin, as described previously (Bouxsein et al., 2010 ). An upper threshold of 1000 Hounsfield units and a lower threshold of 220 Hounsfield units were used to delineate each pixel as 'bone' or 'non-bone'. Representative three-dimensional cross-sectional images for each genotype within the young and aged groups are shown in gray scale. Trabecular bone volume per total volume (BV/TV), mean trabecular thickness (Tb. Th), mean trabecular number (Tb. N, and mean trabecular separation (Tb. Sp) were calculated using Scanco μCT V6.1 software.
The cortical ROI was defined as extending 262.5 μm distally and 262.5 μm proximally from the midshaft. An upper threshold of 1000 Hounsfield units and a lower threshold of 260 Hounsfield units were used to delineate each pixel as 'bone' or 'non-bone'. Cortical area per total area (Ct. Ar/Tt. Ar), average cortical thickness (Ct. Th), periosteal surface and endosteal surface were calculated using Scanco μCT V6.1 software.
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Porosity
High-resolution images of femurs were acquired by using a Scanco μCT 35 device (Bruettisellen, Switzerland). The femurs were scanned with a source voltage of 55 kV, a source current of 142 μA and an isotropic voxel size of 6 μm. Porosity was assessed from the midshaft and extending 600 μm toward the proximal femur head. An upper threshold of 1000 Hounsfield units and a lower threshold of 447 Hounsfield units were used to delineate each pixel as 'bone' or 'pores'. After scanning, porosity was calculated using Scanco μCT V6.1 software.
Histological analysis
To measure dynamic bone formation parameters, mice were injected intraperitoneally with calcein (Sigma, St Louis, MO, USA; 30 mg/kg body weight) and xylenol orange (Sigma, St Louis, MO, USA; 90 mg/kg body weight) on day 9 and day 2 before tissue harvest. Mouse hind limbs were excised, cleaned of soft tissue and fixed in 3.7% formaldehyde for 72 hours. Isolated bone tissue was dehydrated in graded alcohols (70 to 100%), cleared in xylene and embedded in methyl methacrylate (80% methyl methacrylate, 20% dibutyl phthalate, 2.5% benzoyl peroxide) by standard methods. Femurs placed in plastic blocks were cut longitudinally to expose trabecular bone using a Polycut-S motorized microtome (Reichert-Jung, Nossloch, Germany). Consecutive 5-μm sections were collected beginning 25 μm into trabecular bone for histological analysis. For all animals, except those in the aged Terc −/− and Wrn −/− Terc −/− groups, at least nine consecutive sections were used for analysis; in the latter two groups, at least 18 consecutive sections were used.
Femur sections were deplasticized in xylene and assessed for kinetic parameters of bone formation. Selected ROIs (100 μm distal to the growth plate and 50 μm in from the endosteal cortical bone) were visualized using a Nikon Eclipse 90i microscope. Image capture was performed using NIS Elements Imaging Software 3.10 Sp2 and a Nikon DS-Fi1 camera using Nikon 4×/0.2 Plan Apo and 40×/0.95 Plan Apo objectives. The Bioquant Osteo II digitizing system (R&M Biometrics, Nashville, TN, USA) was used for image analysis according to the manufacturer's instructions. Mineralizing surface (MS/BS %) and MAR (μm/day) were quantified from ROIs in trabecular bone using a Nikon 20×/0.75 Plan Apo objective. BFR was calculated from mineralizing surface and MAR. Femur tissue sections were then stained with Goldner's Trichrome or TRAP as previously described (Brennan et al., 2011; Singh et al., 2013) . Osteoid (mm), osteoblast number (Ob N/BS, /mm) and osteoclast number (OCL N/BS, /mm) were quantified within the ROI described above (Parfitt et al., 1987) using Nikon 40×/0.95 Plan Apo objectives. Adipocytes (adipocyte vol/tissue vol) were identified morphologically and quantified as previously described (Elbaz et al., 2009 ) using a Nikon 20×/0.75 Plan Apo objective. Image capture was performed as described above.
Statistics
To determine the effects of genotypes, two-way analysis of variance (ANOVA) was used with the following factors: age (young and aged) and genotype (WT, Wrn Terc −/− mice (within group comparison), and to compare between age-grouped genotypes (intergroup comparison). All statistical analyses were performed using GraphPad Prism 4.0 software (San Diego, CA, USA). An adjusted P-value of <0.05 was considered significant for all analyses. All statistical tests are two-sided. Data are represented as mean ± standard error of the mean (s.e.m.). (Parfitt, 1984; Kleerekoper et al., 1985; Aaron et al., 1987; Rehman et al., 1994; Mullender et al., 2005; Pernow et al., 2009; Macdonald et al., 2011) Trabecular thickness Decreased (Parfitt, 1984; Kleerekoper et al., 1985; Aaron et al., 1987; Rehman et al., 1994; Mullender et al., 2005; Pernow et al., 2009; Macdonald et al., 2011) --Trabecular number Decreased (Parfitt, 1984; Kleerekoper et al., 1985; Aaron et al., 1987; Rehman et al., 1994; Mullender et al., 2005; Pernow et al., 2009; Macdonald et al., 2011) Trabecular separation Increased (Parfitt, 1984; Kleerekoper et al., 1985; Aaron et al., 1987; Rehman et al., 1994; Mullender et al., 2005; Pernow et al., 2009; Macdonald et al., 2011 ) Cortical bone volume Decreased (Rehman et al., 1994; Clarke et al., 1996; Bell et al., 1999; Mullender et al., 2005; Macdonald et al., 2011) --Cortical thickness Decreased (Rehman et al., 1994; Clarke et al., 1996; Bell et al., 1999; Mullender et al., 2005; Macdonald et al., 2011) --Porosity Increased (Feik et al., 1997; Bousson et al., 2001; Ostertag et al., 2009; Nishiyama et al., 2010; Zebaze et al., 2010; Macdonald et al., 2011) --Osteoblast number Decreased (Parfitt, 1984; Kleerekoper et al., 1985; Aaron et al., 1987; Rehman et al., 1994; Mullender et al., 2005; Pernow et al., 2009; Macdonald et al., 2011 ) OB function:
MS/BS MAR BFR Osteoid
Decreased (Parfitt, 1984; Kleerekoper et al., 1985; Aaron et al., 1987; Rehman et al., 1994; Mullender et al., 2005; Pernow et al., 2009; Macdonald et al., 2011 )
Osteoclast number Unchanged (Parfitt, 1984; Kleerekoper et al., 1985; Aaron et al., 1987; Rehman et al., 1994; Mullender et al., 2005; Pernow et al., 2009; Macdonald et al., 2011) --Adipocytes Increased (Ostertag et al., 2009; Zebaze et al., 2010) --Arrows represent relative increase or decrease compared to young WT. m, months.
